MARKER COMPOSITION COMPRISING APOLIPOPROTEIN M FOR DIAGNOSING ALZHEIMER'S DISEASE

• 1. 用于检测硫化氢或测量硫化氢浓度的组合物，以及包含该组合物作为有效成分的用于诊断或成像活体内炎症、有缺氧损伤的组织或癌症的组合物 [P] . 中国专利： CN112714650A . 2021-04-27
• 2. 包含抗-ATIC自身免疫抗体的肝癌诊断标记物以及包含其抗原的肝癌诊断用组合物 [P] . 中国专利： CN103732627B . 2016.08.17
• 3. USE OF A DIAGNOSTIC MARKER COMPOSITION COMPRISING APOLIPOPROTEIN M FOR DIAGNOSING ALZHEIMER'S DISEASE [P] . 欧洲知识产权局专利： EP2995956B1 . 2017-11-15

  机译： 含载脂蛋白M的诊断标记物成分在诊断老年痴呆症中的应用

• 4. Marker composition comprising apolipoprotein M for diagnosing Alzheimer's disease [P] . 韩国专利： KR101509641B1 . 2015-04-06

  机译： 包含载脂蛋白M的标志物组合物，用于诊断阿尔茨海默氏病

• 5. PROTEINIC MARKER FOR DIAGNOSING ALZHEIMER'S DISEASE AND A COMPOSITION CONTAINING THE SAME FOR DIAGNOSING ALZHEIMER'S DISEASE [P] . 韩国专利： KR20120041821A . 2012-05-03

  机译： 用于诊断老年痴呆症的蛋白质标记物和包含用于诊断老年痴呆症的成分的组合物

• 1. Apolipoprotein A1, the neglected relative of Apolipoprotein E and its potential role in Alzheimer's disease [J] . Kristina Endres 中国神经再生研究（英文版） . 2021,第011期
• 2. A non-invasive, rapid method to genotype late-onset Alzheimer’s disease-related apolipoprotein E gene polymorphisms [J] . Li Yi, Ting Wu, Wenyuan Luo, 中国神经再生研究（英文版） . 2014,第001期
• 3. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease (published erratum appears in N Engl J Med 1998 Apr 30;338(18):1325) (see comments) [J] . Mayeux R, Saunders AM, Shea S, The New England journal of medicine . 1998,第8期
• 4. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment [J] . Ba M., Ng K. P., Gao X., European journal of neurology: the official journal of the European Federation of Neurological Societies . 2019,第5期
• 5. Cerebrospinal fluid apolipoprotein e concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease [J] . SchmidtC., BeckerH., ZerrI. American journal of Alzheimer's disease and other dementias . 2014,第1期
• 6. Wavelets based decomposition and classification of diseased fMRI brain images for inter racial disease types of Alzheimer's Vs tumors using SOFM and enhancement by LVQ neural networks [C] . Manokar Nandhini Vigneshwar, Manokar Vigneshwar, Rinesh, 2012 2nd IEEE International Conference on Parallel Distributed and Grid Computing. . 2012
• 7. Apolipoprotein E Immunotherapy for the Preclinical Treatment of Alzheimer Disease and Cerebral Amyloid Angiopathy [D] . Xiong, Monica. 2021
• 8. Thematic Review Series: ApoE and Lipid Homeostasis in Alzheimer’s Disease: Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins [O] . Tien-Phat V. Huynh, Albert A. Davis, Jason D. Ulrich, 2017
• 9. The standardization of cerebrospinal fluid markers and neuropathological diagnoses brings to light the frequent complexity of concomitant pathology in Alzheimer's disease: The next challenge for biochemical markers? [O] . Tanguy Fenouil, Anthony Fourier, Isabelle Quadrio, 2019

• 1. Markers of inflammation and cardiovascular disease in recently diagnosed celiac disease patients [J] . Walter F Tetzlaff ,Tomás Merono ,Martin Menafra . 世界心脏病学杂志：英文版（电子版） . 2017,第5期
• 2. The blood-brain barrier models to study apolipoprotein E genotypes in Alzheimer’s disease [J] . Irundika HK Dias ,Rachelle Taiwo ,Dan Ma . 中国神经再生研究:英文版 . 2022,第9期
• 3. Fragmentation of brain apolipoprotein E(ApoE)and its relevance in late onset Alzheimer's disease [J] . Ernest Asiamah ,Jingjing He ,Ruiyun Guo . 解剖学杂志 . 2021,第S01期
• 4. 纳米通道技术用于老年痴呆症致病蛋白与小分子作用的研究 [C] . 汪海燕 ,应佚伦 ,李扬 . 第一届国际微纳尺度生物医学分离和分析技术学术会议暨第六届全国微全分析学术会议 . 2010
• 5. 包含企业社会责任的多目标投资组合模型的构建——企业社会责任量化与多目标投资组合管理 [A] . 王媛媛 . 2010